Anti-Infective Drugs Market Global Report 2017

Anti-infecive drugs market covers the drugs that are used for the treatment of infectious diseases such as Zika, tuberculosis, typhoid, vaginosis, syphilis, human papillomarivus, human immunodeficiency virus/AIDS, influenza, and other infectious diseases. Some of the major drugs used for the treatment of infectious diseases are Harvoni, Sovaldi, Baxdela, Anthim (obiltoxaximab), Vaxchora, Vemlidy, Prevnar 13, and Zinplava.

The global anti-infective drugs market was estimated to be around $114 billion as of 2016. The anti-infective drugs market made up around 10.5% of the overall pharmaceuticals market in 2016. The anti-infective drugs market was the sixth largest market in the global pharmaceutical market in 2016.

Strategic Collaboration
Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the infectious diseases drugs market are strategically partnering and collaborating with other companies and government agencies to broaden their products, technologies and services. For instance, in January 2016, Takeda announced development of Zika vaccine with upto $312 million funding from the Biomedical Advanced Research and Development Authority (BARDA).

Product Launch
Companies in this market are working towards constant innovation in design and technology to make infectious drugs that are more efficant. In December 2015, Sanofi launched Dengvaxia in Mexico after receiving approval from Federal Commission for the Protection. Dengvaxia is used in the treatment of Dengue.

1. Anti-Infective Drugs Market Characteristics;

2. Anti-Infective Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Anti-Infective Drugs Market Customer Information;

5. Anti-Infective Drugs Market Segmentation;
5.1. Global Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 5.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Anti-Infective Drugs Market Trends And Strategies; 5.3 Global Anti-Infective Drugs Market Trends And Strategies;

6. Anti-Infective Drugs Market Regional And Country Analysis;
6.1. Global Anti-Infective Drugs Market, 2016, By Region; 6.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Anti-Infective Drugs Market, 2016, By Country; 6.4. Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors;
7.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Anti-Infective Drugs Expenditure, Global;

8. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country;

9. Anti-Infective Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Hiv, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Anti-Infective Drugs Market;
10.1.1. Asia-Pacific Anti-Infective Drugs Market Overview; 10.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis; 10.3. China Anti-Infective Drugs Market; 10.3.1. China Anti-Infective Drugs Market Overview; 10.3.2. China Anti-Infective Drugs Historic Market, 2012 - 2016; 10.3.3. China Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.3.4. China Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.3.5. China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.4. India Anti-Infective Drugs Market; 10.4.1. India Anti-Infective Drugs Market Overview; 10.4.2. India Anti-Infective Drugs Historic Market, 2012 - 2016; 10.4.3. India Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.4.4. India Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.4.5. India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.5. Japan Anti-Infective Drugs Market; 10.5.1. Japan Anti-Infective Drugs Market Overview; 10.5.2. Japan Anti-Infective Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.5.5. Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.6. Australia Anti-Infective Drugs Market; 10.6.1. Australia Anti-Infective Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.6.4. Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

11. Western Europe Anti-Infective Drugs Market;
11.1.1. Western Europe Anti-Infective Drugs Market Overview; 11.1.2. Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.2. Western Europe Anti-Infective Drugs Market: Country Analysis; 11.3. UK Anti-Infective Drugs Market; 11.3.1. UK Anti-Infective Drugs Market Overview; 11.3.2. UK Anti-Infective Drugs Historic Market, 2012 - 2016; 11.3.3. UK Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.3.5. UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.4. Germany Anti-Infective Drugs Market; 11.4.1. Germany Anti-Infective Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.4.4 Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.5 France Anti-Infective Drugs Market; 11.5.1 France Anti-Infective Drugs Historic Market, 2012 - 2016; 11.5.2 France Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.5.3 France Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.5.4 France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.6. Italy Anti-Infective Drugs Market; 11.6.1. Italy Anti-Infective Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.6.4. Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.7. Spain Anti-Infective Drugs Market; 11.7.1. Spain Anti-Infective Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.7.4. Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

12. Eastern Europe Anti-Infective Drugs Market;
12.1.1. Eastern Europe Anti-Infective Drugs Market Overview; 12.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis; 12.3. Russia Anti-Infective Drugs Market; 12.3.1. Russia Anti-Infective Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.3.4. Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

13. North America Anti-Infective Drugs Market;
13.1.1. North America Anti-Infective Drugs Market Overview; 13.1.2. North America Anti-Infective Drugs Historic Market, 2012 - 2016; 13.1.3. North America Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.2. North America Anti-Infective Drugs Market: Country Analysis; 13.3. USA Anti-Infective Drugs Market; 13.3.1. USA Anti-Infective Drugs Historic Market, 2012 - 2016; 13.3.2. USA Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.3.4. USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

14. South America Anti-Infective Drugs Market;
14.1.1. South America Anti-Infective Drugs Market Overview; 14.1.2. South America Anti-Infective Drugs Historic Market, 2012 - 2016; 14.1.3. South America Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.2. South America Anti-Infective Drugs Market: Country Analysis; 14.3. Brazil Anti-Infective Drugs Market; 14.3.1. Brazil Anti-Infective Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.3.4. Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

15. Middle East Anti-Infective Drugs Market;
15.1.1. Middle East Anti-Infective Drugs Market Overview; 15.1.2. Middle East Anti-Infective Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);

16. Africa Anti-Infective Drugs Market;
16.1.1. Africa Anti-Infective Drugs Market Overview; 16.1.2. Africa Anti-Infective Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Anti-Infective Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);

17. Anti-Infective Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Glaxosmithkline; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Bristol-Myers Squibb Company; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Anti-Infective Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer